Home > Healthcare > Medical Devices > Diagnostic Devices > IVD Quality Control Market

IVD Quality Control Market Share

Report ID: GMI9695
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

IVD Quality Control Market Share

The competitive landscape in the market is dynamic and highly competitive. Major players, such as Bio-Rad Laboratories, Thermo Fisher Scientific, and F. Hoffmann-La Roche Ltd. hold a significant share due to their robust R&D capabilities, extensive distribution networks, and a broad product portfolio. However, smaller, niche players are emerging, offering specialized quality control solutions, which increases competition. Additionally, these market participants are actively engaged in strategic collaborations, partnerships, mergers, etc., to maintain their position in the market, capture the highest market share, and outperform the competition.

For instance, in March 2021, Bio-Rad Laboratories, Inc. announced a global partnership with F. Hoffmann-La Roche AG. This collaboration granted customers access to Bio-Rad Laboratories, Inc.'s extensive InteliQ product lineup and Unity QC data management solutions, complemented by training and support services.

IVD Quality Control Market Companies

Prominent players operating in the IVD quality control industry include:

Abbott
Agilent Technologies
Becton, Dickinson and Company
Bio-Rad Laboratories
Bio-Techne Corporation
Danaher Corporation
F. Hoffmann-La Roche
Helena Laboratories Corporation
Hologic
Merck
QIAGEN
QuidelOrtho Corporation
Randox Laboratories
Siemens Healthineers
Sysmex Corporation
Technopath Manufacturing
Thermo Fisher Scientific

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global IVD quality control industry was valued at USD 1.3 billion in 2023 and is set to grow at a 4.2% CAGR from 2024 to 2032, driven by the increasing demand for accurate diagnostic testing.

The quality control segment dominated the market in 2023, accounting for USD 859.6 million, due to its critical role in ensuring the reliability and accuracy of diagnostic tests.

North Americas IVD quality control industry recorded USD 493.2 million in 2023 and is anticipated to reach USD 697.6 million by 2032, largely due to the expanding elderly population with higher diagnostic testing needs.

Key players in the sector include Abbott, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne Corporation, Danaher Corporation, F. Hoffmann-La Roche, Helena Laboratories Corporation, Hologic, and Merck.